Explore
Trendline
Bayer to Acquire Perfuse Therapeutics in $2.45 Billion Deal to Enhance Ophthalmology Pipeline
Bayer to Acquire Perfuse Therapeutics in $2.45 Billion Deal to Enhance Ophthalmology Pipeline
Read More
Trendline
Bayer Acquires Perfuse Therapeutics to Enhance Ophthalmology Pipeline
Bayer Acquires Perfuse Therapeutics to Enhance Ophthalmology Pipeline
Read More
Trendline
Bayer's $2.45 Billion Acquisition of Perfuse Therapeutics Aims to Revolutionize Eye Disease Treatment
Bayer's $2.45 Billion Acquisition of Perfuse Therapeutics Aims to Revolutionize Eye Disease Treatment
Read More
Trendline
Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline
Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline
Read More
Trendline
SK Capital Partners Sells Noramco and Affiliates to Siegfried Holding AG
SK Capital Partners Sells Noramco and Affiliates to Siegfried Holding AG
Read More
Trendline
ESTEVE Expands in EU and USA, Strengthening Global Healthcare Presence
ESTEVE Expands in EU and USA, Strengthening Global Healthcare Presence
Read More
Trendline
GameStop Proposes $56 Billion Acquisition of eBay, Potentially Transforming Secondhand Apparel Market
GameStop Proposes $56 Billion Acquisition of eBay, Potentially Transforming Secondhand Apparel Market
Read More
Trendline
Alcami Expands Global Reach with Acquisition of Tjoapack
Alcami Expands Global Reach with Acquisition of Tjoapack
Read More
Trendline
Pfizer Exceeds Wall Street Expectations with Strong Q1 Earnings and Revenue Growth
Pfizer Exceeds Wall Street Expectations with Strong Q1 Earnings and Revenue Growth
Read More
Trendline
Eli Lilly Expands U.S. Investment with Additional $4.5 Billion in Indiana
Eli Lilly Expands U.S. Investment with Additional $4.5 Billion in Indiana
Read More
Trendline
Arriva Group Acquires 80% Stake in La Linea Spa, Expanding Presence in Italy's Veneto Region
Arriva Group Acquires 80% Stake in La Linea Spa, Expanding Presence in Italy's Veneto Region
Read More
Trendline
LEO Pharma Reports 9% Revenue Growth in Q1 2026, Expands Innovation Pipeline
LEO Pharma Reports 9% Revenue Growth in Q1 2026, Expands Innovation Pipeline
Read More